Evaluation of glycosphingolipid clearance in patients with Fabry disease treated with agalsidase alfa who switched to agalsidase beta (the INFORM study)

Autor: Barranger, John A., Gambello, Michael J., Goker-Alpan, Ozlem, Maegawa, Gustavo H.B., Nedd, Khan J., Gruskin, Daniel J., Blankstein, Larry, Weinreb, Neal J.
Zdroj: In Molecular Genetics and Metabolism February 2014 111(2):S24-S24
Databáze: ScienceDirect